Completed PHASE4 INTERVENTIONAL 3-arm NCT01912677

Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy

Sponsor: Bill and Melinda Gates Foundation

Conditions Hypertension in Pregnancy Preeclampsia

Interventions Labetalol Methyldopa Nifedipine

Updated 7 times since 2017 Last updated: Nov 6, 2018 Started: Apr 30, 2015 Primary completion: Sep 30, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension in Pregnancy and Preeclampsia and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE4

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bill and Melinda Gates Foundation
Daga Memorial Women's Hospital, Nagpur, India
Government Medical College, Nagpur
Gynuity Health Projects
University of British Columbia

Data source: Gynuity Health Projects

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nagpur, India